About CDK5 and ABL1 enzyme substrate 2
CDK5 and ABL1 enzyme substrate 2 (CABLES2) is a protein
from Homo sapiens identified by UniProt accession
Q9BTV7, 478 residues long.
MolForge cross-references it against 0 known binders and
41 disease associations.
Target properties
| Protein name | CDK5 and ABL1 enzyme substrate 2 |
| UniProt accession | Q9BTV7 |
| Gene | CABLES2 |
| Organism | Homo sapiens |
| Length | 478 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (41)
Diseases linked to this target (Open Targets).
- Immature Reticulocyte Fraction Measurement · score 0.37
- colorectal cancer · score 0.36
- serum albumin measurement · score 0.29
- total blood protein measurement · score 0.23
- platelet crit · score 0.16
- esophageal cancer · score 0.15
- body height · score 0.14
- intestinal cancer · score 0.14
- colonic neoplasm · score 0.10
- mean corpuscular volume · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BTV7-F1 | alphafold | PREDICTED | 59.78 | — |
Amino-acid sequence (478 residues)
MAAAAAGGAP GPAPGPAGPP PPAAPTSAAR APPQALRRRG DSRRRQAALF FLNNISLDGR PPSLGPGGEK PPPPPAEARE PPAPPPPEPP TGLPARTPAP QGLLSPTQVP TGLGLDGQRQ RKRVTSQRCS LEFLEDAVGC APAQRTKHTS GSPRHKGLKK THFIKNMRQY DTRNSRIVLI CAKRSLCAAF SVLPYGEGLR ISDLRVDSQK QRHPSGGVSV SSEMVFELEG VELGADGKVV SYAKFLYPTN ALVTHKSDSH GLLPTPRPSV PRTLPGSRHK PAPTKSAPAS TELGSDVGDT LEYNPNLLDD PQWPCGKHKR VLIFASYMTT VIEYVKPSDL KKDMNETFRE KFPHVKLTLS KIRSLKREMR SLSEECSLEP VTVAMAYVYF EKLVLQGKLS KQNRKLCAGA CVLLAAKISS DLRKSGVTQL IDKLEERFRF NRRDLIGFEF TVLVALELAL YLPENQVLPH YRRLTQQF
Explore CDK5 and ABL1 enzyme substrate 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets